Form D — Abrexa Pharmaceuticals, Inc.
0001529349-25-000001 · filed 2025-04-28
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $22,999,999
- Total sold
- $22,999,999
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Abrexa Pharmaceuticals, Inc.
- CIK
- 1529349
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 402 W Broadway
SAN DIEGO, CA 92101 - Phone
- (619) 295-5077
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
J. Ernest Villafranca · Executive OfficerSan Diego, CA Find on LinkedIn ↗
-
James J. Truchard · DirectorSan Diego, CA Find on LinkedIn ↗
-
David Hughley · DirectorSan Diego, CA Find on LinkedIn ↗
View original on SEC EDGAR.